Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Intracrine signaling leaves open new therapeutic targets in cardiovascular disease; hypothesis-generating pending rigorous validation.
There is evidence that many peptide growth factors and hormones act in the intracellular space after either internalization or retention in their cells of synthesis. These factors, commonly called intracrines, are structurally diverse while sharing some common functional features. Reports of intracellular peptide hormone binding and action are reviewed here. Also, this laboratory has made proposals regarding the origin and actions of intracrines and these areas are further explored. Intracrine interactions and the relationship of intracrines to transcription factors are discussed. The intracellular/intracrine renin-angiotensin system (iRAS) is reviewed to illustrate the intracrine analogue of a well-established physiological system. The role of intracrine action in metazoan development is also considered.
No takes yet. Share an insight, caveat, or question.
Richard N. Ré (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: